Rita de Cássia Elias Estrela Marins

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Farmácia

Departamento:

Departamento de Fármacos e Medicamentos

ORCID:

https://orcid.org/0000-0002-5653-1690


Formação:
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Doutorado | 2003 - 2007
  • Universidade Federal do Rio de Janeiro

    Química Biológica | Mestrado | 2001 - 2003
  • Instituto Nacional de Câncer

    Farmacologia | Especialização | 2000 - 2001
  • Universidade Federal do Rio de Janeiro

    Farmácia | Graduação | 1995 - 2000
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(70.27% artigos com DOI)

Titulo DOI Ano
Frailty and health-related quality of life among older people living with HIV pre- and post-COVID-19 pandemic onset: A cross-sectional study 10.1016/j.bjid.2024.103723 2024
Extended stability study of an extemporaneously analgesic solution of clonidine, ropivacaine and fentanyl 10.1590/s2175-97902022e191121 2023
DEVELOPMENT AND VALIDATION OF LC-MS/MS METHODS FOR THE SIMULTANEOUS QUANTIFICATION OF SOFOSBUVIR AND ITS MAJOR METABOLITE (GS-331007) IN BLOOD PLASMA, CEREBROSPINAL, AND SEMINAL FLUID: APPLICATION TO A PILOT CLINICAL TRIAL WITH A FOCUS ON ZIKA 10.1002/bmc.5606 2023
Development and validation of liquid chromatography-tandem mass spectrometry method to quantify dasatinib in plasma and its application to a pharmacokinetic study 10.1590/s2175-97902023e21415 2023
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre-Exposure Prophylaxis: Analysis of Potential Interactions 10.1007/s40262-023-01248-0 2023
Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review 10.1007/s40262-023-01291-x 2023
Development, physicochemical evaluation, and in vivo permeation studies of topical formulations containing 0.1% tacrolimus 10.1590/s2175-97902023e201150 2023
Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Brazil 10.1186/s12981-023-00548-6 2023
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study 10.1002/jia2.25896 2022
The effect of dietary fibers on the absorption of oral hypoglycemic drugs: a systematic review of controlled trials 10.1007/s13410-022-01114-y 2022
Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug?drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis 2022
Misoprostol Use Profile in a Public Hospital in Rio de Janeiro/Brazil: From the Perspective of a Hospital Pharmacy Dispensation 10.22533/at.ed.1592282207063 2022
Disulfiram repurposing in the combined chemotherapy of Chagas disease 10.1097/MD9.0000000000000110 2021
Pretreatment and non-specific binding in ultrafiltration device: Impact on protease inhibitor quantification 2020
A novel and simple LC-MS/MS quantitative method for dextromethorphan and dextrorphan in oral fluid 10.4155/bio-2018-0323 2019
Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 AND GST 10.1016/j.bjid.2019.09.003 2019
The Yin and Yang of Tyrosine Kinase Inhibition During Experimental Polymicrobial Sepsis 10.3389/fimmu.2018.00901 2018
Development and validation of a RP-HPLC method for Roflumilast and its degradation products 10.1080/10826076.2018.1436067 2018
Identification, characterization and in silico ADMET prediction of Roflumilast degradation products 10.1016/j.jpba.2017.02.012 2017
A Rapid and Simple HPLC Method for Therapeutic Monitoring of Vancomycin 10.1093/chromsci/bmx089 2017
Randomized Clinical Trial Comparing the Pharmacokinetics of Standard- and Increased-Dosage Lopinavir-Ritonavir Coformulation Tablets in HIV-Positive Pregnant Women 10.1128/aac.02599-13 2014
Implementation of vancomycin dosing nomogram in an electronic prescribing system: an innovative tool in antibiotic stewardship 10.1590/S1984-82502014000300016 2014
Development and validation of a method for allantoin determination in liposomes and pharmaceutical formulations 10.1016/j.saa.2012.02.022 2012
The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men 10.1111/j.1365-2125.2009.03551.x 2010
ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy 10.2217/14622416.10.2.311 2009
Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture 10.2217/14622416.9.3.267 2008
CYP3A5 Genotype Has No Impact on Plasma Trough Concentrations of Lopinavir and Ritonavir in HIV-infected Subjects 10.1038/clpt.2008.12 2008
Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection 10.1002/rcm.3411 2008
A new model for the population pharmacokinetics of didanosine in healthy subjects 2007
Limited penetration of lopinavir and ritonavir in the genital tract of men infected with HIV-1 in Brazil. 2006
Estimating the genetic component (RGC) in pharmacokinetic variability of the antiretroviral didanosine among healthy Brazilians. 2005
Prednisolone: limited sampling strategies for estimating pharmacokinetic parameters. 2004
A Rapid and Sensitive Method for Simultaneous Determination of Lamivudine and Zidovudine in Human Serum by On-Line Solid Phase Extraction Coupled to Liquid Chromatography/Tandem Mass Spectrometry Detection. 2004
Determination of didanosine in human serum by on-line solid phase extraction coupled to HPLC with ESI-MS/MS detection: application to a bioequivalence study 2003
Determination of Stavudine in Human Serum by On-Line Solid Phase Extraction Coupled to High-Performance Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry Detection: Application to a Bioequivalence Study. 2003
Limited-sampling strategy models for estimating the pharmacokinetic parameters of 4-methylaminoantipyrine, an active metabolite of dipyrone. 2001
Modulation of calcium release channel of sarcoplasmic reticulum by amiloride analogs 2000
Eventos:

(3.70% eventos com DOI)

Titulo DOI Ano
Are Age and Sex Relevant Factors for the Pharmacokinetics of Benznidazole in Patients with Chronic Chagas Disease in the Indeterminate Form? 10.13140/RG.2.2.14006.27204 2023
Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Rio de Janeiro, Brazil 2022
No impact of tenofovir/emtricitabine in estradiol exposure among transwomen on oral PrEP: results from the 12-week drug-drug interaction PrEParadas substudy. 2021
No impact of feminizing hormone therapy on daily oral pre-exposure prophylaxis effectiveness among Brazilian trans women vulnerable to HIV infection: the PrEParadas Study 2021
Forced degradation study of roflumilast: odentification and quantification of degradatio products 2014
Characterization of CYP2E1 polymorphisms in patients receiving treatment for TB 2014
Caracterização dos polimorfismos da CYP2E1 em pacientes sob tratamento para tuberculose 2013
Validação de uma metodologia analítica para a quantificação de lopinavir em ritonavir em plasma sanguíneo de mulheres grávidas. 2012
Validação de uma metodologia analítica para quantificação de lopinavir e ritonavir em plasma sanguíneo de mulheres grávidas e sangue de cordão umbilical 2012
Validação de um nomograma de doses de vancomicina no Hospital Universitário Clementino Fraga Filho ? UFRJ 2012
DEMOGRAPHIC PROFILE AND EVALUATING THE DEVELOPMENT OF ADVERSE REACTIONS IN WOMEN WITH BREAST CANCER USING TAMOXIFEN 2011
Development and validation of a method to evaluate the extended stability of an analgesic solution 2009
ABCB1 polymorphisms have no impact on the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under stable antiretroviral therapy 2008
ABCB1 polymorphisms have no impact on the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under stable antiretroviral therapy 2008
RELAÇÃO ENTRE ATIVIDADE E GENÓTIPO DE MDR1/ABCB1 EM LINFÓCITOS DE INDIVÍDUOS HIV1 POSITIVOS 2006
ESTUDO PILOTO DA MODULAÇÃO DA GLICOPROTEÍNA-P POR RITONAVIR E LOPINAVIR ATRAVÉS DE CITOMETRIA DE FLUXO. 2005
DETERMINATION OF LOPINAVIR AND RITONAVIR IN BLOOD PLASMA AND SEMINAL PLASMA OF MEN INFECTED WITH HIV-1 BY LC/MS/MS: IMPLICATIONS FOR SEXUAL TRANSMISSION OF HIV-1. 2004
DETERMINAÇÃO SIMULTÂNEA DE ZIDOVUDINA (AZT) E LAMIVUDINA (3TC) EM SORO HUMANO COM APLICAÇÃO A UM ESTUDO DE BIOEQUIVALÊNCIA. 2003
DESENVOLVIMENTO E VALIDAÇÃO DE MÉTODOS E PARA A QUANTIFICAÇÃO DE ZIDOVUDINA (AZT), ESTAVUDINA (D4T) E LAMIVUDINA (3TC) 2002
Estudo de bioequivalência de duas formulações farmacêuticas de meloxicam 2001
Modelos de amostragem limitada para prever parâmetros farmacocinéticos de meloxicam 2001
Limited sampling models for amoxycilin based on data from bioequivalences studies 2000
Limited sampling models for 4-methylaminoantypirine- a dypirone metabolite- based on data from a bioequivalence study 2000
Estudo em bicamadas lipídicas da ação do fenamil e diclorobenzamil na cinética do receptor de rianodina 1999
Efeito dos análogos da amilorida sobre o canal de cálcio do retículo sarcoplasmático 1998
Análogos da amilorida modulam a liberação de cálcio, pelo retículo sarcoplasmático de fibras musculares esqueléticas 1997
Avaliação de métodos para a detecção de Listéria monocytogenes em alimentos 1995
Publicações:
Minha Rede: